Detalhe da pesquisa
1.
Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.
Int J Mol Sci
; 22(3)2021 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573134
2.
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Breast Cancer Res
; 22(1): 124, 2020 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176887
3.
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Eur J Cancer Care (Engl)
; 29(4): e13253, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32578279
4.
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition.
Breast Cancer Res
; 21(1): 69, 2019 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126332
5.
HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.
Cancers (Basel)
; 15(3)2023 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765720
6.
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer.
JNCI Cancer Spectr
; 7(2)2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806942
7.
FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.
Pharmaceutics
; 14(2)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213975
8.
miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.
Pharmgenomics Pers Med
; 14: 1263-1273, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616173
9.
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports.
World J Gastroenterol
; 26(16): 1979-1986, 2020 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390708
10.
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer.
Clin Cancer Res
; 26(1): 35-45, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597662
11.
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Breast
; 54: 286-292, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242755
12.
Biliary cystadenocarcinoma with mesenchymal stroma.
Clin Transl Oncol
; 12(3): 234-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231130
13.
Adjuvant chemotherapy for stages II, III and IV of colon cancer.
Clin Transl Oncol
; 11(8): 526-33, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19661027